Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution.
Fabiani E, Cristiano A, Hajrullaj H, Falconi G, Leone G, Voso MT. Fabiani E, et al. Among authors: hajrullaj h. Mediterr J Hematol Infect Dis. 2023 Nov 1;15(1):e2023064. doi: 10.4084/MJHID.2023.064. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 38028397 Free PMC article. Review.
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression.
Rivalta B, Attardi E, Cifaldi C, Rosti V, Pacillo L, Hajrullaj H, Di Cesare S, Amodio D, Algeri M, Luciani M, Barzaghi F, Finocchi A, Di Matteo G, Aiuti A, Locatelli F, Voso MT, Palumbo G, Cancrini C. Rivalta B, et al. Among authors: hajrullaj h. Br J Haematol. 2024 Jan;204(1):e6-e10. doi: 10.1111/bjh.19150. Epub 2023 Nov 3. Br J Haematol. 2024. PMID: 37921255 No abstract available.
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Guarnera L, Fabiani E, Attrotto C, Hajrullaj H, Cristiano A, Latagliata R, Fenu S, Buccisano F, Irno-Consalvo M, Conti C, Voso MT, Maurillo L. Guarnera L, et al. Among authors: hajrullaj h. Ann Hematol. 2023 Nov;102(11):3015-3023. doi: 10.1007/s00277-023-05384-2. Epub 2023 Aug 3. Ann Hematol. 2023. PMID: 37535147 Free PMC article.
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept.
Travaglini S, Gurnari C, Antonelli S, Marchesi F, De Angelis G, Ottone T, Divona M, Cristiano A, Hajrullaj H, Mengarelli A, Voso MT. Travaglini S, et al. Among authors: hajrullaj h. Br J Haematol. 2023 Oct;203(2):327-330. doi: 10.1111/bjh.18991. Epub 2023 Jul 23. Br J Haematol. 2023. PMID: 37485586 No abstract available.
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Falconi G, Galossi E, Fabiani E, Pieraccioli M, Travaglini S, Hajrullaj H, Cerretti R, Palmieri R, Latagliata R, Maurillo L, Voso MT. Falconi G, et al. Among authors: hajrullaj h. Sci Rep. 2022 Dec 8;12(1):21231. doi: 10.1038/s41598-022-24644-1. Sci Rep. 2022. PMID: 36481766 Free PMC article.